NEFL and myeloid sarcoma: Recent studies based on national health registries proposed NfL as a potential marker for predicting MS risk and disease course, even at the earlier stages of the disease in subjects with radiologically isolated syndrome (RIS) and clinically isolated syndrome (CIS) (Bjornevik et al., 2020, Preziosa et al., 2020).